DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20211801

Continuing COVID vaccination will break the chain of virus transmission: myth or reality

Achhelal R. Pasi

Abstract


As countries roll out vaccines that prevent COVID-19, many scientists are reluctant to say with certainty that the vaccines prevent person to person transmission. All the vaccines authorised for emergency use do this,however there are no conclusive evidence that the COVID-19 vaccine prevents the infection. The limited data available suggests that the vaccines will at least partly reduce transmission, and the studies to determine this with more clarity are underway. One should wait for more data and conclusive evidence to make a statement like “ongoing COVID vaccination will break the chain of transmission”. A vaccine that is highly effective at preventing people from acquiring infection would help to reduce transmission, and till then we need to follow the COVID prevention measures. The best way to prevent infection from COVID-19 is to avoid exposure to the virus.a

COVID-19 is the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) whose main mode of transmission between people, is when an infected person is in close contact with another person, apart from fomite and airborne transmission. Infection occurs when virus enters in the body and begin to multiply while disease occurs when the cells in the body are damaged — as a result of the infection — and signs and symptoms of an illness appear. Approximately 40% to 45% of those infected with SARS-CoV-2 remain asymptomatic and asymptomatic persons can transmit SARS-CoV-2 to others. Asymptomatic SARS-CoV-2 infections have been demonstrated to present with viral loads similar to symptomatic infections. Contact tracing and modelling studies suggest presymptomatic and asymptomatic patients are responsible for approximately 50% of all COVID-19 transmission events.


Keywords


COVID-19, SARS-CoV-2, COVID-19 vaccine, Chain of transmission, COVID prevention

Full Text:

PDF

References


Corona Virus Disease (COVID – 19). Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19. Accessed on 05 March 2021.

Understanding infection vs. disease. Available at: https://www.mayoclinic.org/diseases-conditions/inf ectious-diseases/in-depth/germs/art 20045289#:~:tex t=Infection%2C%20often%20the%20first%20step,symptoms%20of%20an%20illness%20appear. Accessed on 05 March 2021.

Oran DP, Topol EJ. Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review. Ann Intern Med. 2020;M20-3012.

Lee S, Kim T, Lee E, Lee C, Kim H, Rhee H, et al. Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea. JAMA Intern Med. 2020;180:1447.

Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, et al. The implications of silent transmission for the control of COVID-19 outbreaks. PNAS. 2020;117:17513-5.

Du Z, Xu X, Wu Y, Wang L, Cowling BJ, Meyers LA. Serial Interval of COVID-19 among Publicly Reported Confirmed Cases. Emerg Infect Dis. 2020;26:1341-3.

Infection prevention and you: breaking the chain of transmission. Available at: http://www.ashnha. com/wp-content/uploads/2017/10/Break-the-Chain-of-Infection.pdf. Accessed on 05 March 2021.

Does the COVID vaccine stop transmission? Available at: https://economictimes.indiatimes.com/ news/international/world-news/does-the-covid-19-vaccine-stop-transmission/articleshow/81183856.cm s?from=mdr. Accessed on 05 March 2021.

Types of Vaccines. Available at: https://www.cdc.gov/coronavirus/2019-ncov/vacc ines/different-vaccines/how-they-work.html. Accessed on 05 March 2021.

Coronavirus vaccine: Covishield vs. Covaxin, all you need to know about India’s approved homegrown vaccines. Available at: https://timesofindia.india times.com/life-style/health-fitness/health-news/ coronavirus-vaccine-covishield-vs-covaxin-all-you-need-to-know-about-indias-approved-homegrown-vaccines/photostory/80091866.cms. Accessed on 05 March 2021.

Tuberculosis and COVID-19. Available at: https://www.who.int/teams/global-tuberculosis-programme/covid-19#:~:text=Tuberculosis%20(TB) %20and,slower%20onset%20of%20disease. Accessed on 05 March 2021.

Adesanya OA, Christabel I, Uche-Orji, Adedeji YA. Bacillus Calmette-Guerin (BCG): the adroit vaccine AIMS Microbiol. 2000;7(1):96-113.

Comstock G. The International tuberculosis campaign: a pioneering venture in mass vaccination and research. Clin Infect Dis. 1994;19:528-40.

Fully vaccinated against COVID-19? Here are dos, don’ts by CDC and word of caution on variants. Available at: https://www.hindustantimes.com /world-news/fully-vaccinated-against-covid-19-here-s-cdc-s-list-of-dos-and-donts-1016152844065 27.html. Accessed on 05 March 2021.

COVID-19 vaccines: Operational guidelines; Ministry of Health & Family Welfare, GOI. Available at: https://www.mohfw.gov.in/pdf/COVID 19VaccineOG111Chapter16.pdf. Accessed on 11 March 2021.